title: Management of postpneumonectomy syndrome by intrapleural injection of sulfur hexafluoride. Case report.
abstract: Left postpneumonectomy syndrome was managed by injection of sulfur hexafluoride (SF6) into the pleural space. This measure permitted irradiation of a contralateral, second primary lung cancer without resulting pulmonary fibrosis. Such use of SF6 may be an option for prophylaxis against postpneumonectomy syndrome.
authors.affiliation: Second Department of Surgery, School of Medicine, University of Tokushima, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Uyama
authors.forename: Y
authors.initials: Y
authors.lastname: Monden
authors.forename: S
authors.initials: S
authors.lastname: Sakiyama
authors.forename: T
authors.initials: T
authors.lastname: Fukumoto
authors.forename: M
authors.initials: M
authors.lastname: Sumitomo
authors.forename: K
authors.initials: K
authors.lastname: Harada
mesh_terms: D000368:Aged; D003131:Combined Modality Therapy; D003371:Cough / Q000188:drug therapy / Q000209:etiology; D004417:Dyspnea / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D015552:Injections, Intralesional; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D008297:Male; D016609:Neoplasms, Second Primary / Q000188:drug therapy* / Q000532:radiotherapy; D010994:Pleura; D011013:Pneumonectomy; D011183:Postoperative Complications / Q000188:drug therapy* / Q000209:etiology; D013459:Sulfur Hexafluoride / Q000627:therapeutic use*; D013577:Syndrome
chemical_list: D013459:Sulfur Hexafluoride